EW FY 2020 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4.4B+0.9% YoY

Gross Profit

$3.3B74.9% margin

Operating Income

$1.3B29.5% margin

Net Income

$823M18.8% margin

EPS (Diluted)

$1.30

Cash Flow

Operating Cash Flow

$1.1B

Free Cash Flow

$647M

Stock-Based Comp.

$93M

Balance Sheet

Total Assets

$7.2B

Total Liabilities

$2.7B

Stockholders' Equity

$4.6B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.4B	$4.3B	+0.9%
Gross Profit	$3.3B	$3.2B	+3.0%
Operating Income	$1.3B	$1.2B	+8.2%
Net Income	$823M	$1.0B	-21.3%